BBIO

Neutral

BridgeBio Pharma, Inc. $BBIO Position Lifted by Franklin Resources Inc.

Franklin Resources Inc. raised its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 49.9% during the fourth quarter, according...

tickerreport 3 days ago 0

Bullish

Encaleret NDA, Acoramidis Progress, and Buyback Could Be A Game Changer For BridgeBio (BBIO)

BridgeBio Pharma (BBIO) recently announced significant clinical and regulatory advancements, including an FDA submission for encaleret in ADH1 and fur...

Simply Wall Street 4 weeks ago 0